Humacyte, Inc. Increase (Decrease) in Accounts Receivable
Humacyte, Inc. (HUMA) reported Increase (Decrease) in Accounts Receivable of -$111.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-12
- Humacyte, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$104.00K.
- Humacyte, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$7.00K, a 102.27% decline year-over-year.
- Humacyte, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$637.00K.
- Humacyte, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $684.00K.
- Humacyte, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $261.00K.
- Humacyte, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- Humacyte, Inc. increase (decrease) in accounts receivable for fiscal 2023 was -$31.00K.
- Humacyte, Inc. increase (decrease) in accounts receivable for fiscal 2022 was -$145.00K, a 330.16% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$104.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$111.00K 10-Q · filed 2026-08-12 | -$748.00K derived: sum of 3 quarters · filed 2026-08-12 | -$64.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$7.00K 10-Q · filed 2026-05-13 | -$644.00K derived: sum of 2 quarters · filed 2026-05-13 | $40.00K derived: sum of 3 quarters · filed 2026-05-13 | -$54.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $47.00K derived: sum of 2 quarters · filed 2026-03-27 | -$47.00K derived: sum of 3 quarters · filed 2026-08-12 | $261.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $684.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $590.00K derived: sum of 2 quarters · filed 2026-08-12 | $898.00K 10-Q · filed 2025-11-12 | $898.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $214.00K 10-Q · filed 2026-08-12 | $214.00K derived: sum of 3 quarters · filed 2026-08-12 | $214.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $308.00K 10-Q · filed 2026-05-13 | $308.00K derived: sum of 2 quarters · filed 2026-05-13 | $308.00K derived: sum of 3 quarters · filed 2026-05-13 | $308.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $0.00 derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-13 | $0.00 derived: sum of 2 quarters · filed 2025-05-13 | $0.00 derived: sum of 3 quarters · filed 2025-05-13 | $0.00 derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-03-31 | -$31.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | -$31.00K 10-Q · filed 2024-11-08 | -$31.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$31.00K 10-Q · filed 2024-08-13 | -$31.00K derived: sum of 3 quarters · filed 2024-08-13 | -$1.30M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$31.00K 10-Q · filed 2024-05-13 | -$31.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.30M derived: sum of 3 quarters · filed 2024-05-13 | -$233.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$1.27M derived: sum of 2 quarters · filed 2024-03-28 | -$202.00K derived: sum of 3 quarters · filed 2024-03-28 | -$145.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$202.00K derived: sum of 2 quarters · filed 2023-11-09 | -$145.00K 10-Q · filed 2023-11-09 | -$209.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.13M 10-Q · filed 2023-08-14 | $1.06M derived: sum of 3 quarters · filed 2023-08-14 | $612.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $57.00K 10-Q · filed 2023-05-12 | -$7.00K derived: sum of 2 quarters · filed 2023-05-12 | -$456.00K derived: sum of 3 quarters · filed 2023-05-12 | $78.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$513.00K derived: sum of 2 quarters · filed 2023-03-24 | $21.00K derived: sum of 3 quarters · filed 2023-03-24 | $63.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $85.00K derived: sum of 2 quarters · filed 2022-11-10 | $127.00K 10-Q · filed 2022-11-10 | -$379.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $534.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $576.00K 10-Q · filed 2022-08-12 | $70.00K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $42.00K 10-Q · filed 2022-05-13 | -$464.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$506.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$488.00K 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $18.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |